Healthy Lifestyle Interventions for Non-communicable Disease Prevention in Saudi Arabia: A Scoping Review
Abstract
Non-communicable diseases (NCDs), including diabetes, cardiovascular disease (CVD), and obesity, are considered major contributors to mortality and morbidity. Modifiable lifestyle determinants, including unhealthy diets and physical inactivity, play a major role in their progression. Interventions such as lifestyle modification are critical to reduce the onset of NCDs and improve the overall health of the population. This study aimed to synthesize the evidence on lifestyle interventions targeting NCD risk reduction among the population of Saudi Arabia by highlighting the implementing strategies, key outcomes, and recommendations. A scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines, given the heterogeneity of the evidence in terms of population, study design, and intervention. Databases searched included PubMed and Google Scholar, yielding 13 studies that met the inclusion criteria. Key outcomes such as improvement in blood pressure, weight, and risk reduction were observed in addition to dietary modification and physical activities that improved health outcomes. Mindfulness and behavioral strategies support compliance with lifestyle changes. Community initiatives and primary healthcare prevention programs enhance the effectiveness of interventions among various types of populations and those with different levels of education. Culturally tailored and structured…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.